Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder

Journal of Psychiatric Research

Volumn 47, Issue 6, 2013, Pages 699-705

  Bernstein, Hans Gert ^a   Dobrowolny, Henrik ^a   Schott, Björn H ^b   Gorny, Xenia ^b   Becker, Veronika ^a   Steiner, Johann ^a   Seidenbecher, Constanze I ^b   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

A kinase anchor protein (AKAP) 5 79; Bipolar disorder; Immunohistochemistry; Prefrontal cortex; Stereology

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA3; A KINASE ANCHORING PROTEIN 5; BETA ADRENERGIC RECEPTOR; CALMODULIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIBETA; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DISORDER; BRAIN ATROPHY; BRAIN CELL; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; LONG TERM CARE; LUNG EMBOLISM; MALE; NERVE CELL; NEUROPIL; NEUROTRANSMISSION; PNEUMONIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SUICIDE; TIME OF DEATH;

EID: 84875887365     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.12.020     Document Type: Article

References (64)

1. Bernstein H.G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998, 83:867-875.
2. Bernstein H.G., Baumann B., Danos P., Diekmann S., Bogerts B., Gundelfinger E.D., et al. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. Journal of Neurocytology 1999, 8:655-662.
3. Bernstein H.G., Sahin J., Smalla K.H., Gundelfinger E.D., Bogerts B., Kreutz M.K. A reduced number of cortical neurons show increased caldendrin protein levels in chronic schizophrenia. Schizophrenia Research 2007, 96:246-256.
4. Bernstein H.G., Ernst T., Lendeckel U., Bukowska A., Ansorge S., Stauch R., et al. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. Journal of Psychiatric Research 2009, 43:1095-1105.
5. Bielau H., Trübner K., Krell D., Agelink M.W., Bernstein H.G., Stauch R., et al. Volume deficits of subcortical nuclei in mood disorders A postmortem study. European Archives of Psychiatry and Clinical Neuroscience 2005, 255:401-412.
6. Bora E., Fornito A., Yücel M., Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biological Psychiatry 2010, 67:1097-1105.
7. Cassidy F., Zhao C., Badger J., Claffey E., Dobrin S., Roche S., et al. Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13. American Journal of Medical Genetics B Neuropsychiatric Genetics 2007, 144B:pp.791-pp.801.
8. Chang A., Li P.P., Warsh J.J. Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. Journal of Neurochemistry 2003, 84:pp.781-pp.791.
9. Chiesa A., Crisafulli C., Porcelli S., Balzarro P., Han C., Patkar A.A., et al. Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. International Journal of Psychiatry and Clinical Practice 2012, 16:18-26.
10. Clinton S.M., Meador-Woodruff J.M. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 2004, 29:pp.1353-pp.1362.
11. Colledge M., Dean R.A., Scott G.K., Langeberg L.K., Huganir R.L., Scott J.D. Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 2000, 27:107-119.
12. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. Journal of Medical Genetics 2005, 42:193-204.
13. Declaration of Helsinki - ethical principles for medical research involving human subjects 1984.
14. Dell'Acqua M.L., Smith K.E., Gorski J.A., Horne E.A., Gibson E.S., Gomez L.L. Regulation of neuronal PKA signaling through AKAP targeting dynamics. European Journal of Cell Biology 2006, 85:627-633.
15. Dell'Osso B., Palazzo M.C., Oldani L., Altamura A.C. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. CNS Neuroscience Therapeutics 2011, 17:723-732.
16. Diagnostic and statistical manual of mental disorders 1987, (DSM-III)-Revised, American Psychiatric Association. 3rd ed.
17. Eastwood S.L., Harrison P.J. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biological Psychiatry 2010, 67:1010-1016.
18. Emamghoreishi M., Li P.P., Schlichter L., Parish S.V., Cooke R., Warsh J.J. Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder. Biological Psychiatry 2000, 48:665-673.
19. Fountoulakis K.N. The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder. Current Pharmaceutical Design 2012, 18:1605-1608.
20. Fraser I.D., Cong M., Kim J., Rollins E.N., Daaka Y., Lefkowitz R.J., et al. Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Current Biology 2000, 10:409-412.
21. Gamo N.J., Arnsten A.F. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behavioral Neuroscience 2011, 125:282-296.
22. Gardner L.A., Naren A.P., Bahouth S.W. Assembly of an SAP97-AKAP79-cAMP-dependent protein kinase scaffold at the type 1 PSD-95/DLG/ZO1 motif of the human beta (1)-adrenergic receptor generates a receptosome involved in receptor recycling and networking. Journal of Biological Chemistry 2007, 282:5085-5099.
23. Gigante A.D., Bond D.J., Lafer B., Lam R.W., Young L.T., Yatham L.N. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disorders 2012, 14:478-487.
24. Gorny X., Mikhaylova M., Seeger C., Reddy P.P., Reissner C., Schott B.H., et al. AKAP79/150 interacts with the neuronal calcium-binding protein caldendrin. Journal of Neurochemistry 2012, 122:714-726.
25. Grozeva D., Kirov G., Ivanov D., Jones I.R., Jones L., Green E.K., et al. Wellcome Trust Case Control Consortium. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Archives of General Psychiatry 2010, 67:318-327.
26. Hahn C.G., Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disorders 1999, 1:81-86.
27. Karege F., Schwald M., El Kouaissi R. Drug-induced decrease of protein kinase A activity reveals alteration in BDNF expression of bipolar affective disorder. Neuropsychopharmacology 2004, 29:805-812.
28. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neurosciences 2007, 61:3-19.
29. Kealey C., Roche S., Claffey E., McKeon P. Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene. American Journal of Medical Genetics B Neuropsychiatric Genetics 2005, 136B:75-80.
30. Kerner B., Brugman D.L., Freimer N.B. Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics 2007, 144B:74-78.
31. Kim H.K., Andreazza A.C. The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder. Expert Review of Neurotherapeutics 2012, 12:849-859.
32. Lee K.W., Woon P.S., Teo Y.Y., Sim K. Genome-wide association studies (GWAS) and copy number variation (CVN) studies of the major psychoses: what have we learnt?. Neuroscience and Biobehavioral Reviews 2012, 36:556-577.
33. Liu J., Juo S.H., Dewan A., Grunn A., Tong X., Brito M., et al. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Molecular Psychiatry 2003, 8:333-342.
34. Maddock R.L., Buonocore M.H. MR spectroscopic studies of the brain in psychiatric disorders. Current Topics in Behavioural Neuroscience 2012, 11:199-251.
35. Mangiavacchi S., Wolf M.E. D1 dopamine receptor stimulation increases the rate of AMPA receptor insertion onto the surface of cultured nucleus accumbens neurons through a pathway dependent on protein kinase A. Journal of Neurochemistry 2004, 888:1261-1271.
36. Mathieu F., Miot S., Etain B., El Khoury M.A., Chevalier F., Bellivier F., et al. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behavior and Brain Function 2008, 17:2.
37. McInnis M.G., Lan T.H., Willour V.L., McMahon F.J., Simpson S.G., Addington A.M., et al. Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Molecular Psychiatry 2003, 8:288-298.
38. Nakatani N., Hattori E., Ohnishi T., Dean B., Iwayami Y., Matsumoto I., et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Human Molecular Genetics 2006, 15:1949-1962.
39. Novak G., Seeman P., Tallerico T. Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 2006, 59:61-68.
40. Perez J., Tardito D., Racagni G., Smeraldi E., Zanardi R. cAMP signaling pathway in depressed patients with psychotic features. Molecular Psychiatry 2002, 7:208-212.
41. Prata D.P., Breen G., Munro J., Sinclair M., Osborne S., Li T., et al. Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics 2006, 16:229-230.
42. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
43. Rankovic V., Landgraf P., Kanyshova T., Ehling P., Meuth S.G., Kreutz M.R., et al. Modulation of calcium-dependent inactivation of L-type Ca2+ channels via β-adrenergic signaling in thalamocortical relay neurons. PLoS One 2011, 6:e27474.
44. Richter S., Gorny X., Marco-Pallares J., Krämer U.M., Machts J., Barman A., et al. A potential role for a genetic variation of AKAP5 in human aggression and anger control. Frontiers of Human Neuroscience 2011, 5:175.
45. Robertson H.R., Gibson E.S., Benke T.A., Dell'Acqua M.L. Regulation of postsynaptic structure and function by an A-kinase anchoring protein-membrane-associated guanylate kinase scaffolding complex. Journal of Neuroscience 2009, 29:7929-7943.
46. Sanderson J.L., Dell'Acqua M.L. AKAP signaling complexes in regulation of excitatory synaptic plasticity. Neuroscientist 2011, 17:321-336.
47. Sandoz G., Thümmler S., Duprat F., Feliciangeli S., Vinh J., Escoubas P., et al. AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels. EMBO Journal 2006, 25:5864-5872.
48. Savitz J.B., Drevets W.C. Neuroreceptor imaging in depression. Neurobiology of Disease 2013, 52:49-65.
49. Schwayze R.D., Lise M.F., Levison J.N., Phillips A., El-Husseini A. Modulation of dopamine mediated phosphorylation of AMPA receptors by PSD-95 and AKAP79/150. Neuropharmacology 2004, 47:764-778.
50. Scott J.D. A-kinase-anchoring proteins and cytoskeletal signalling events. Biochemical Society Transaction 2003, 31:87-89.
51. Seguardo R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.L., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. American Journal of Human Genetics 2003, 73:49-62.
52. Selemon L.D., Mrzljak J., Kleinman J.E., Herman M.M., Goldman-Rakic P.S. Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Archives of General Psychiatry 2003, 60:69-77.
53. Spiechowicz M., Bernstein H.G., Dobrowolny H., Lesniak W., Mawrin C., Bogerts B., et al. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain. Neurochemistry International 2006, 49:487-493.
54. Spitzer R.L., Andreasen N.C., Endicott J. Schizophrenia and other psychotic disorders in DSM-III. Schizophrenia Bulletin 1978, 4:489-510.
55. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34:1363-1380.
56. Sutrala S.R., Goossens D., Williams N.M., Heyrman L., Adolfsson R., Norton N., et al. Gene copy number variation in schizophrenia. Schizophrenia Research 2007, 96:93-99.
57. Ting T.J., Peça J., Feng G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annual Reviews of Neuroscience 2012, 35:49-71.
58. Tsai J.S. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1. Medical Hypotheses 2008, 70:548-550.
59. Ulfig N., Neudörfer F., Bohl J. Development-related expression of AKAP79 in the striatal compartments of the human brain. Cells Tissues Organs 2001, 168:319-329.
60. Van Rheenen T.E., Rossell S.L. Genetic and neurocognitive foundations of emotion abnormalities in bipolar disorder. Cognitive Neuropsychiatry 2012, 10.1080/13546805.2012.690938.
61. Wang H.Y., Markowitz P., Levinson D., Undie A.S., Friedman E. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. Journal of Psychiatric Research 1999, 33:171-179.
62. Wilson G.M., Flibotte S., Chopra V., Melnyk B.L., Honer W.G., Holt R.A. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Human Molecular Genetics 2006, 15:743-749.
63. Wong W., Scott J.D. AKAP signalling complexes: focal points in space and time. Nature Reviews in Molecular and Cellular Biology 2004, 12:959-970.
64. Zhao J., Bao A.M., Qi X.R., Kamphuis W., Luchetti S., Lou J.S., et al. Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. Journal of Affective Disorders 2012, 138:494-502.